Cargando…

Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation

BACKGROUND: Cardiomyocyte apoptosis is critical for the development of coxsackievirus B3- (CVB3-) induced myocarditis, which is a common cardiac disease that may result in heart failure or even sudden death. Previous studies have associated CVB3-induced apoptosis with the downregulation of antiapopt...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ping, Yan, Yaoyao, Shi, Youyang, Cheng, Bo, Zhan, Yi, Wang, Qiaoyu, Ye, Qiaofang, Weng, Yawen, Wu, Tingting, Wu, Rongzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431489/
https://www.ncbi.nlm.nih.gov/pubmed/30984342
http://dx.doi.org/10.1155/2019/9496419
_version_ 1783405936496345088
author Li, Ping
Yan, Yaoyao
Shi, Youyang
Cheng, Bo
Zhan, Yi
Wang, Qiaoyu
Ye, Qiaofang
Weng, Yawen
Wu, Tingting
Wu, Rongzhou
author_facet Li, Ping
Yan, Yaoyao
Shi, Youyang
Cheng, Bo
Zhan, Yi
Wang, Qiaoyu
Ye, Qiaofang
Weng, Yawen
Wu, Tingting
Wu, Rongzhou
author_sort Li, Ping
collection PubMed
description BACKGROUND: Cardiomyocyte apoptosis is critical for the development of coxsackievirus B3- (CVB3-) induced myocarditis, which is a common cardiac disease that may result in heart failure or even sudden death. Previous studies have associated CVB3-induced apoptosis with the downregulation of antiapoptotic proteins. Here, attempts were made to examine whether nicotinic acetylcholine receptors (nAChRs), especially α3β4-nAChRs, were a novel therapeutic antiapoptotic target via the activation of survivin, a strong antiapoptotic protein, in viral myocarditis (VMC). METHODS AND RESULTS: In the present study, we demonstrated that nAChRs, α3β4-nAChR subunits in particular, were present and upregulated in CVB3-infected neonatal rat cardiomyocytes (NRC) and H9c2 cells by RT-qPCR. The function of α3β4-nAChRs was next examined using its specific blocker α-CTX AuIB in vitro. The results of the TUNEL assay and western blot experiments showed that the block of α3β4-nAChRs abrogated nicotine-mediated protection of NRC from CVB3-induced apoptosis, and this effect displayed a substantial correlation with the protein expressions of pAkt, survivin, and Cleaved Caspase-3. Hence, the involvement of the PI3K/Akt pathway was further verified by LY294002, a selective inhibitor of PI3K. As a result, nicotine-mediated induction of pAkt and survivin was abolished by LY294002; meanwhile, apoptotic NRC were increased accompanied by an increase of Cleaved Caspase-3 expression. Regarding CVB3-infected BALB/c mice, the α-CTX AuIB- and LY294002-treated groups had a lower survival rate, deteriorative ventricular systolic function, and more severe inflammation than the nicotine-treated group and the modulation of pAkt, survivin, and Cleaved Caspase-3 protein expressions was similar to that in CVB3-infected NRC. In addition, we found that a nicotinic agonist reduced CVB3 replication in a dose-dependent manner in vitro, which indicates that nAChR activation may serve as a possible protection mechanism of CVB3-induced myocarditis. CONCLUSIONS: Our study demonstrated that α3β4-nAChR subunits are essential in the nicotine-mediated antiapoptotic effect of protecting cardiomyocytes from CVB3-induced apoptosis in vivo and in vitro. This protection correlated with the PI3K/Akt pathway and the inducement of the antiapoptotic protein survivin. A combination of these mechanisms serves as a novel protective response to treat viral myocarditis.
format Online
Article
Text
id pubmed-6431489
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64314892019-04-14 Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation Li, Ping Yan, Yaoyao Shi, Youyang Cheng, Bo Zhan, Yi Wang, Qiaoyu Ye, Qiaofang Weng, Yawen Wu, Tingting Wu, Rongzhou Oxid Med Cell Longev Research Article BACKGROUND: Cardiomyocyte apoptosis is critical for the development of coxsackievirus B3- (CVB3-) induced myocarditis, which is a common cardiac disease that may result in heart failure or even sudden death. Previous studies have associated CVB3-induced apoptosis with the downregulation of antiapoptotic proteins. Here, attempts were made to examine whether nicotinic acetylcholine receptors (nAChRs), especially α3β4-nAChRs, were a novel therapeutic antiapoptotic target via the activation of survivin, a strong antiapoptotic protein, in viral myocarditis (VMC). METHODS AND RESULTS: In the present study, we demonstrated that nAChRs, α3β4-nAChR subunits in particular, were present and upregulated in CVB3-infected neonatal rat cardiomyocytes (NRC) and H9c2 cells by RT-qPCR. The function of α3β4-nAChRs was next examined using its specific blocker α-CTX AuIB in vitro. The results of the TUNEL assay and western blot experiments showed that the block of α3β4-nAChRs abrogated nicotine-mediated protection of NRC from CVB3-induced apoptosis, and this effect displayed a substantial correlation with the protein expressions of pAkt, survivin, and Cleaved Caspase-3. Hence, the involvement of the PI3K/Akt pathway was further verified by LY294002, a selective inhibitor of PI3K. As a result, nicotine-mediated induction of pAkt and survivin was abolished by LY294002; meanwhile, apoptotic NRC were increased accompanied by an increase of Cleaved Caspase-3 expression. Regarding CVB3-infected BALB/c mice, the α-CTX AuIB- and LY294002-treated groups had a lower survival rate, deteriorative ventricular systolic function, and more severe inflammation than the nicotine-treated group and the modulation of pAkt, survivin, and Cleaved Caspase-3 protein expressions was similar to that in CVB3-infected NRC. In addition, we found that a nicotinic agonist reduced CVB3 replication in a dose-dependent manner in vitro, which indicates that nAChR activation may serve as a possible protection mechanism of CVB3-induced myocarditis. CONCLUSIONS: Our study demonstrated that α3β4-nAChR subunits are essential in the nicotine-mediated antiapoptotic effect of protecting cardiomyocytes from CVB3-induced apoptosis in vivo and in vitro. This protection correlated with the PI3K/Akt pathway and the inducement of the antiapoptotic protein survivin. A combination of these mechanisms serves as a novel protective response to treat viral myocarditis. Hindawi 2019-03-07 /pmc/articles/PMC6431489/ /pubmed/30984342 http://dx.doi.org/10.1155/2019/9496419 Text en Copyright © 2019 Ping Li et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Ping
Yan, Yaoyao
Shi, Youyang
Cheng, Bo
Zhan, Yi
Wang, Qiaoyu
Ye, Qiaofang
Weng, Yawen
Wu, Tingting
Wu, Rongzhou
Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation
title Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation
title_full Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation
title_fullStr Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation
title_full_unstemmed Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation
title_short Nicotinic Agonist Inhibits Cardiomyocyte Apoptosis in CVB3-Induced Myocarditis via α3β4-nAChR/PI3K/Akt-Dependent Survivin Upregulation
title_sort nicotinic agonist inhibits cardiomyocyte apoptosis in cvb3-induced myocarditis via α3β4-nachr/pi3k/akt-dependent survivin upregulation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431489/
https://www.ncbi.nlm.nih.gov/pubmed/30984342
http://dx.doi.org/10.1155/2019/9496419
work_keys_str_mv AT liping nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT yanyaoyao nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT shiyouyang nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT chengbo nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT zhanyi nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT wangqiaoyu nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT yeqiaofang nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT wengyawen nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT wutingting nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation
AT wurongzhou nicotinicagonistinhibitscardiomyocyteapoptosisincvb3inducedmyocarditisviaa3b4nachrpi3kaktdependentsurvivinupregulation